scholarly journals COMPARATIVE STUDY BETWEEN SINGLE ANASTMOSIS DUODENO-ILEAL BYPASS-SLEEVE AND MINI-GASTRIC BYPASS AFTER FAILED SLEEVE GASTRECTOMY IN MORBIDLY OBESE PATIENTS

2019 ◽  
Vol 70 (4) ◽  
pp. 409-428
Author(s):  
Alaa Moustafa ◽  
Karim Abdel-Samee ◽  
Abdallah Ibrahim ◽  
Moustafa Mohamed
QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
A Abdelhamid ◽  
S Albalkiny ◽  
K Abdel-Samee ◽  
A Mustafa

Abstract Background Metabolic and bariatric surgery is a proven therapy for the treatment of obesity and its related comorbidities. Malabsorptive operations usually offer a higher rate of metabolic improvement, despite higher rate of complications and secondary effects. Objectives To compare Single Anastomosis Duodeno–Ileal bypass with Sleeve gastrectomy (SADIS) and Mini-Gastric Bypass operation as two types of bariatric surgeries with regard to weight loss, metabolic outcome and nutritional deficiencies within one year of post-operative follow up. Methods We performed a prospective comparison of 40 morbidly obese patients submitted to SADIS (n. = 20) and MGB (n. = 20) between July 2016 to July 2017 with one year of postoperative follow up. Results The groups were nearly similar in terms of age and sex. The SADI-S group had BMI of (47.4 vs 46.1) with 100% prevalence of DM in both groups, hypertension in SADIS 70% vs 65% in MGB and almost equal incidence of dyslipidemia. The SADI-S group presented markedly higher percentage of EWL of 91.4% vs 71.6% after one year. Control of DM, with HbA1c below 6%, was obtained in 85% in both groups with more decrease in mean HbA1c of SADIS being 5.44 vs 5.815 in MGB after one year. Most patients abandoned antidiabetic therapy or at least were controlled by less medications and lower doses. The SADI-S group presented remission of hypertension by 90% of patients as those of MGB but with far less medications. Lipid profile improvement was noticed in both groups with slightly higher resolution in SADIS group by 95% vs 90% for total cholesterol, 85% in both groups for T.G, 80% vs 85% for LDL, 65% vs 70% for HDL in SADIS and MGB patients respectively. Although the nutritional deficiency is still a considerable concern after SADIS, ours study didn’t show intense difference from MGB provided that proper vitamin supplementation and patient compliance are maintained postoperatively. Conclusion When compared to gastric bypass, SADI-S appears to be an effective and safe therapeutic technique with excellent short-term results for treating morbid obesity and its associated comorbidities with a low rate of nutritional complications. Proving its safety and efficacy by further studies will grant it more popularity in the future.


2019 ◽  
Vol 7 (10) ◽  
pp. 72-83
Author(s):  
Yasser AliElsayed ◽  
◽  
Atif MohamedAbdElLatif ◽  
Tamer YoussefMohamed ◽  
Hesham MohamedAbdalla ◽  
...  

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Alaa A Sabry ◽  
Karim S Abd El-Sameea ◽  
Ahmed A Abd Elmoez

Abstract Background Single anastomosis sleeve ileal bypass (SASI) procedure appears as anew metabolic and bariatric surgery based on santoro's operation, in which sleeve gastrectomy is followed by side to side gastro-ileal loop anastomosis. Aim of the Work to compare between Single Anastomosis Sleeve Ileal Bypass (SASI) and Mini Gastric Bypass (OAGB) in treatment of morbid obesity. Patients and Methods Our study was a prospective randomized comparative study in Ain Shams University hospitals involving 50 patients suffering from morbid obesity and in whom surgical management was indicated. Our patients were randomly divided using closed envelopment method into two groups: Group (1): (25 patients) were treated by laparoscopic SASI. Group (2): (25 patients) were treated by laparoscopic MGB. Results One year after the surgery, there was significant diabetic remission rate and there was improvement of most of obesity-associated metabolic parameters Conclusion Our study suggests that both SASI and MGB are highly effective in controlling diabetes mellitus, hypertension and hyperlipidemia.


QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
H Z Shaker ◽  
M Z Abdelaziz ◽  
M M Abdelaziz ◽  
A H Afify ◽  
A M S Mohamed

Abstract Background Type 2 diabetes mellitus (T2DM) is now a global health priority. The World Health Organization estimates that between 2000 and 2030, the number of diabetic patients will increase by 114%. T2DM and morbid obesity are conditions representing increasing public health threats. They are associated with significant morbidity and mortality, and despite lifestyle modifications and medical support, glycemic control remains difficult to achieve in obese diabetic patients. Objective To compare the effect of laproscopic mini gastric bypass and laproscopic sleeve gastrectomy in controlling type 2 DM obese patients. Patients and Methods Our study was conducted on 40 adult morbid obese patients with T2DM. Twenty patient underwent laparoscopic mini-gastric bypass and the other 20 patient underwent sleeve gastrectomy. All of these patients were followed up preoperative and postoperative at 1, 3, 6, 9 and 12 months by measuring BMI, EWL%, Fasting blood glucose level, 2 hours post prandial blood glucose level, HbA1C also postoperative gastrografin study to exclude complications. Results Our study demonstrated the superiority of MGB over SG in controlling T2DM along 1 year of follow up with lower 1 year HBA1C, FBG, 2HPP blood glucose level in bypass group in comparison with SG group. The results of our study regarding mini gastric bypass MGB patient group showed total remission rate (85%), the other 15% of patients achieved improvement of glycemic control, regarding antidiabetic treatment only 3 out of 20 needed postoperative treatment. The results of our study regarding sleeve gastrectomy patient group showed total remission rate (50%) the other 50% of patients achieved improvement of T2DM control, regarding antidiabetic treatment 9 out of 20 needed postoperative treatment. Conclusion late postoperative complications and long-term maintenance of glycemic control need to be determined by further studies on a larger scale of patients and bigger duration of follow up.


Sign in / Sign up

Export Citation Format

Share Document